Cencora, Inc. (NYSE:COR) Given Consensus Rating of “Moderate Buy” by Brokerages

Shares of Cencora, Inc. (NYSE:COR) have been assigned an average rating of “Moderate Buy” from the fourteen brokerages that are currently covering the company, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation and eleven have issued a buy recommendation on the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $367.75.

COR has been the subject of several recent research reports. Morgan Stanley set a $342.00 price target on Cencora in a report on Friday, May 8th. Wells Fargo & Company decreased their price objective on Cencora from $429.00 to $331.00 and set an “overweight” rating on the stock in a research note on Monday, May 11th. Robert W. Baird lowered their price objective on Cencora from $420.00 to $339.00 and set an “outperform” rating on the stock in a research report on Thursday, May 7th. Evercore set a $360.00 price objective on Cencora in a research note on Wednesday, April 8th. Finally, Citigroup cut their price objective on Cencora from $405.00 to $355.00 and set a “buy” rating for the company in a research note on Thursday, May 7th.

Cencora Trading Down 0.1%

Shares of Cencora stock opened at $307.72 on Friday. The company’s fifty day simple moving average is $279.98 and its 200-day simple moving average is $317.68. The stock has a market capitalization of $59.87 billion, a PE ratio of 23.60, a P/E/G ratio of 1.71 and a beta of 0.58. Cencora has a 1-year low of $244.82 and a 1-year high of $377.54. The company has a debt-to-equity ratio of 3.40, a current ratio of 0.95 and a quick ratio of 0.59.

Cencora (NYSE:COR) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $4.75 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). The business had revenue of $78.36 billion for the quarter, compared to the consensus estimate of $81.09 billion. Cencora had a net margin of 0.78% and a return on equity of 135.20%. The company’s revenue was up 3.9% on a year-over-year basis. During the same period in the previous year, the firm earned $4.42 EPS. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. As a group, equities analysts anticipate that Cencora will post 17.79 earnings per share for the current year.

Cencora Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Friday, May 15th were issued a dividend of $0.60 per share. The ex-dividend date of this dividend was Friday, May 15th. This represents a $2.40 annualized dividend and a yield of 0.8%. Cencora’s payout ratio is currently 18.40%.

Cencora declared that its board has authorized a share buyback program on Thursday, May 21st that permits the company to repurchase $2.00 billion in shares. This repurchase authorization permits the company to repurchase up to 3.9% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company’s board of directors believes its stock is undervalued.

Insider Activity

In other news, Director Lauren M. Tyler acquired 550 shares of Cencora stock in a transaction dated Monday, June 22nd. The stock was purchased at an average cost of $270.23 per share, with a total value of $148,626.50. Following the completion of the purchase, the director directly owned 4,359 shares in the company, valued at approximately $1,177,932.57. This trade represents a 14.44% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.38% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Cencora

Institutional investors have recently bought and sold shares of the business. JFS Wealth Advisors LLC increased its holdings in Cencora by 30.2% during the 4th quarter. JFS Wealth Advisors LLC now owns 125 shares of the company’s stock worth $42,000 after purchasing an additional 29 shares during the last quarter. Apollon Wealth Management LLC boosted its stake in shares of Cencora by 0.5% during the 4th quarter. Apollon Wealth Management LLC now owns 6,527 shares of the company’s stock valued at $2,205,000 after buying an additional 30 shares during the last quarter. Accent Capital Management LLC boosted its stake in shares of Cencora by 36.1% during the 4th quarter. Accent Capital Management LLC now owns 113 shares of the company’s stock valued at $38,000 after buying an additional 30 shares during the last quarter. MCF Advisors LLC grew its position in shares of Cencora by 11.0% during the fourth quarter. MCF Advisors LLC now owns 303 shares of the company’s stock worth $102,000 after buying an additional 30 shares in the last quarter. Finally, CYBER HORNET ETFs LLC grew its position in shares of Cencora by 6.8% during the fourth quarter. CYBER HORNET ETFs LLC now owns 485 shares of the company’s stock worth $164,000 after buying an additional 31 shares in the last quarter. Hedge funds and other institutional investors own 97.52% of the company’s stock.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.